Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple ...

Virtual CT scans cut patient radiation exposure in half during PET/CT studies Date: June 13, 2022 Source: Society of Nuclear Medicine and Molecular Imaging Summary: A novel artificial intelligence ...

To assess the performance of molecular imaging to evaluate AIA, researchers used an ultra-low dose 18 F-FDG total-body PET/CT acquisition protocol to scan 30 participants (24 with AIA and six with ...

Other imaging tests, such as CT and MRI scans, are often done in combination with PET scans. CT scans and MRIs can provide more information on cancerous (malignant) tumors and lesions.

PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...

PET imaging can also help determine how well cancer treatment is working. It’s an effective way to find cancer, but a negative PET scan doesn’t always mean there’s no cancer.

The study examined PET/CT scans with radioactively labeled choline—a promising molecular imaging tool which has been shown to be more accurate than conventional imaging techniques such as CT ...

Doctors might combine PET scans with a CT scan to get a more detailed image of the specific area. If they combine these two scans, they may refer to it as a PET- CT scan.

Investigators conducted PET/CT scans on days 4 (D4) and 21 (D21) of cycle 1 of salvage therapy. They wanted to test the value of early prognostic evaluation in the relapsed/refractory (R/R) setting.

Reston, VA— In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18 F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active ...

FDG-PET/CT has the greatest utility in settings of suspected ovarian cancer recurrence, particularly in patients with rising CA-125 levels and negative conventional imaging.